CN109602859A - 苗药廖氏化风丹在制备防治黑色素瘤药物中的应用 - Google Patents

苗药廖氏化风丹在制备防治黑色素瘤药物中的应用 Download PDF

Info

Publication number
CN109602859A
CN109602859A CN201910049186.2A CN201910049186A CN109602859A CN 109602859 A CN109602859 A CN 109602859A CN 201910049186 A CN201910049186 A CN 201910049186A CN 109602859 A CN109602859 A CN 109602859A
Authority
CN
China
Prior art keywords
pill
melanoma
liao shi
huafeng
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910049186.2A
Other languages
English (en)
Other versions
CN109602859B (zh
Inventor
宋晶睿
李艳梅
陈娟
饶青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Key Laboratory of Natural Product Chemistry of Guizhou Academy of Sciences
Original Assignee
Key Laboratory of Natural Product Chemistry of Guizhou Academy of Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Laboratory of Natural Product Chemistry of Guizhou Academy of Sciences filed Critical Key Laboratory of Natural Product Chemistry of Guizhou Academy of Sciences
Priority to CN201910049186.2A priority Critical patent/CN109602859B/zh
Publication of CN109602859A publication Critical patent/CN109602859A/zh
Application granted granted Critical
Publication of CN109602859B publication Critical patent/CN109602859B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538—Schizonepeta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8884—Arisaema, e.g. Jack in the pulpit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了苗药廖氏化风丹在制备防治黑色素瘤药物中的应用，通过在体外运用黑色素瘤细胞WM35、WM239检测发现，廖氏化风丹具有显著的抑制黑色素瘤作用，并通过流式细胞检测其在细胞周期方面的作用，结果表明廖氏化风丹对黑色素瘤细胞周期影响显著，并且药物浓度越高，其阻滞越明显，可作为防治黑色素瘤制剂，制备成药剂学上允许的口服液、注射剂、片剂、胶囊剂、滴丸剂等。

Description

苗药廖氏化风丹在制备防治黑色素瘤药物中的应用
技术领域
本发明属于生物学和医药学技术领域，具体涉及一种苗药廖氏化风丹在制备防治黑色素瘤药物中的应用。
背景技术
苗药廖氏化风丹，由贵州万胜药业有限责任公司生产制造，丸剂，其现有作用：息风镇痉，豁痰开窍。用于风痰闭阻、中风偏瘫、癫痫，面神经麻痹，口眼歪斜。主要成份包括天麻、全蝎、僵蚕、白附子、苍术、天南星、麝香等20余味中药材。朱红色的水丸，剖面显棕黄色；有强烈香气、味辛。
黑色素瘤是由皮肤或其他器官黑素细胞产生的肿瘤，是最具侵袭性的皮肤肿瘤。黑色素瘤在我国发病率虽然在肿瘤中的比重较少，但总体为上升趋势。目前恶性黑色素瘤的治疗方法包括化疗、靶向治疗、免疫治疗及放疗等，但是黑色素瘤对放疗、化疗不敏感，所以治疗效果并不乐观，生物免疫治疗例如黑色素瘤疫苗等大多还处于研发或临床试验阶段。因此，提高早期诊断率，寻找对黑色素瘤的有效治疗药物是目前的首要任务。
发明内容
本发明的目的是针对黑色素瘤治疗困难，寻找出新的治疗黑色素瘤效果显著的药物。
针对上述目的，本发明提供了一种苗药廖氏化风丹作为制备防治黑色素瘤药物中的应用。
本发明在体外运用黑色素瘤细胞WM35、WM239检测发现，廖氏化风丹具有显著的抑制黑色素瘤作用，并通过流式细胞检测其在细胞周期方面的作用，结果表明廖氏化风丹对黑色素瘤细胞周期影响显著，阻滞细胞周期于G2-M期，并且药物浓度越高，其阻滞越明显，可作为防治黑色素瘤药物。
本发明将廖氏化风丹直接制备成防治黑色素瘤的制剂或者与其他防治黑色素瘤的药物复配制备成防治黑色素瘤的复方制剂，其中所述的制剂可以采用药剂学上允许的口服液、注射剂、片剂、胶囊剂、滴丸剂中任意一种。
本发明的有益效果为：与廖氏化风丹的现有用途相比，发明人发现了廖氏化风丹对黑色素瘤具有良好的体外抑制作用，发现了此药的新用途。而廖氏化风丹是已上市的药物，能直接应用于人体而不再需要进行临床安全评估，具有很好的应用前景，可快速提高此产品的市场占有率。
附图说明
图1是不同浓度廖氏化风丹对人黑色素瘤细胞WM35增殖抑制率。
图2是不同浓度廖氏化风丹对人黑色素瘤细胞WM239增殖抑制率。
图3是不同浓度廖氏化风丹对人黑色素瘤细胞WM239周期的影响。
具体实施方式
下面结合附图和实施例对本发明进一步详细说明。
实施例1
苗药廖氏化风丹体外抗黑色素瘤细胞的活性测试
1、实验材料
样品溶液的配制：将廖氏化风丹用DMSO分别配制成浓度为50μg/mL、25μg/mL、12.5μg/mL、6.25μg/mL、3.125μg/mL的样品溶液。
5％MTT溶液的配制：称取MTT粉末0.5g，加入灭菌的PBS 100mL，60℃溶解，0.22μm过滤膜过滤除菌，4℃保存。
细胞系：人黑色素瘤细胞WM35、WM239均为贵州省中国科学院天然产物化学重点实验室保存。人黑色素瘤细胞WM35、WM239于37℃5％CO2培养箱中用含5％FBS的DMEM培养基培养。
DMEM培养基及胰酶购于Hycone公司，胎牛血清(FBS)购于上海启动元生物科技有限公司，四甲基偶氮哩盐(MTT)、二甲基亚飒(DMSO)购于北京索莱宝科技有限公司。
2、实验方法
MTT法测定不同浓度廖氏化风丹对黑色素瘤细胞抑制增殖作用
以5×103/孔的密度，将处于指数增殖期的人黑色素瘤细胞WM35、WM239分别接种于96孔板中，每孔190μL含5％FBS的DMEM培养基，培养24h后，每孔加入10μL含不同浓度廖氏化风丹的样品溶液，每个浓度设5个复孔。另设DMSO对照组和100nmol紫杉醇(PTX)阳性对照组。细胞置37℃培养箱内继续培养72h后，每孔加入20μL5％MTT溶液，继续培养4h后，1200r离心10min，弃去上清，每孔加入160μLDMSO，置振荡仪上充分混匀，采用酶标仪，以570nm为测试波长，630nm为参考波长，测量各孔吸光度计算抑制率，结果见图1和图2。
图1和图2的结果表明，廖氏化风丹对人黑色素瘤细胞WM35、WM239的生长有显著的抑制作用，且廖氏化风丹对WM35和WM239细胞的生长抑制具有显著的浓度依赖性。人黑色素瘤细胞WM35在浓度为25μg/mL的药物浓度下，其抑制率大于90％，在浓度为12.5μg/mL时，其抑制率为60.59％，高于100nmol紫杉醇的抑制率59.48％，处理数据得出半数抑制浓度IC50值WM35:11.85±1.19。人黑色素瘤细胞WM239在浓度为25μg/mL的药物浓度下，其抑制率大于50％，同时高于100nmol紫杉醇的抑制率41.42％，处理数据得出半数抑制浓度IC50值WM239:20.75±2.58。
2、流式细胞仪测定细胞周期的变化
将人黑色素瘤细胞WM35接种于60mm的圆形培养皿，置于37℃培养箱6h待其贴壁，加入含不同浓度廖氏化风丹的样品溶液，终浓度分别为5μg/mL、10μg/mL、20μg/mL，对照组加等量的DMSO，于37℃5％CO2培养箱中培养，收集加药20h的细胞，用500μL体积浓度为75％的乙醇水溶液固定，50μg/mLPI碘化丙啶溶液(含100μg/mLRNase，由PBS缓冲液配制)染色30min，于流式细胞仪上做细胞周期分析，结果见图3。
图3的流式结果表明：廖氏化风丹对人黑色素瘤细胞WM35周期影响显著，阻滞细胞周期于G2-M期，并且药物浓度越高，其阻滞越明显。
由以上结果可知，廖氏化风丹在制备防治黑色素瘤药物或黑色素瘤细胞增殖抑制剂方面具有潜在价值。

Claims (3)

1.苗药廖氏化风丹在制备防治黑色素瘤药物中的应用。
2.根据权利要求1所述的苗药廖氏化风丹在制备防治黑色素瘤药物中的应用，其特征在于：所述的苗药廖氏化风丹直接制备成防治黑色素瘤的制剂或者与其他防治黑色素瘤的药物复配制备成防治黑色素瘤的复方制剂。
3.根据权利要求2所述的苗药廖氏化风丹在制备防治黑色素瘤药物中的应用，其特征在于：所述的制剂为口服液、注射剂、片剂、胶囊剂、滴丸剂中任意一种。
CN201910049186.2A 2019-01-18 2019-01-18 苗药廖氏化风丹在制备防治黑色素瘤药物中的应用 Active CN109602859B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910049186.2A CN109602859B (zh) 2019-01-18 2019-01-18 苗药廖氏化风丹在制备防治黑色素瘤药物中的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910049186.2A CN109602859B (zh) 2019-01-18 2019-01-18 苗药廖氏化风丹在制备防治黑色素瘤药物中的应用

Publications (2)

Publication Number Publication Date
CN109602859A true CN109602859A (zh) 2019-04-12
CN109602859B CN109602859B (zh) 2021-07-16

Family

ID=66017838

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910049186.2A Active CN109602859B (zh) 2019-01-18 2019-01-18 苗药廖氏化风丹在制备防治黑色素瘤药物中的应用

Country Status (1)

Country Link
CN (1) CN109602859B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111773296A (zh) * 2020-03-24 2020-10-16 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 康艾扶正复方在制备抗新型冠状病毒感染药物中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1413704A (zh) * 2002-11-19 2003-04-30 贵州万胜药业有限责任公司 化风丹
CN1634410A (zh) * 2004-11-01 2005-07-06 唐宗园 一种外用中药膏药
CN1923232A (zh) * 2005-09-01 2007-03-07 郑廷彬 一种用于祛风消痰、破瘀软坚的药物组合物及其制备方法和用途
CN108392575A (zh) * 2018-05-30 2018-08-14 贵州万胜药业有限责任公司 廖氏化风丹在制备抗白血病药物中的应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1413704A (zh) * 2002-11-19 2003-04-30 贵州万胜药业有限责任公司 化风丹
CN1634410A (zh) * 2004-11-01 2005-07-06 唐宗园 一种外用中药膏药
CN1923232A (zh) * 2005-09-01 2007-03-07 郑廷彬 一种用于祛风消痰、破瘀软坚的药物组合物及其制备方法和用途
CN108392575A (zh) * 2018-05-30 2018-08-14 贵州万胜药业有限责任公司 廖氏化风丹在制备抗白血病药物中的应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111773296A (zh) * 2020-03-24 2020-10-16 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 康艾扶正复方在制备抗新型冠状病毒感染药物中的应用
CN111773296B (zh) * 2020-03-24 2021-09-03 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 康艾扶正复方在制备抗新型冠状病毒感染药物中的应用

Also Published As

Publication number Publication date
CN109602859B (zh) 2021-07-16

Similar Documents

Publication Publication Date Title
Guan et al. Adjuvant effects of salidroside from Rhodiola rosea L. on the immune responses to ovalbumin in mice
CN105722974A (zh) 全能干细胞的诱导方法、及用该方法制备的全能干细胞
CN101890030B (zh) 抗菌、抗病毒、抗氧化及抗色素沉积的组合物
EP3023104B1 (en) Recombinant ganoderma lucidum immunomodulatory protein (rlz-8) for use in treating melanoma
CN103169737A (zh) 樟芝子实体与破壁灵芝孢子粉的组合物及其在免疫调节中的应用
CN108392575B (zh) 廖氏化风丹在制备抗白血病药物中的应用
CN103505454A (zh) 一种α-微管蛋白抑制剂及其应用
CN109602859A (zh) 苗药廖氏化风丹在制备防治黑色素瘤药物中的应用
CN109453164A (zh) 一种抗肿瘤的联合用药物
CN110946948A (zh) 化风丹在制备抗乳腺癌药物中的应用
CN105749154B (zh) 一种治疗肝癌的益生菌发酵中药复方组合物及其制备和检测方法
CN102335185A (zh) 淫羊藿苷在制备防治支气管哮喘药物中的用途
CN102727579B (zh) 一种用于治疗口腔溃疡的药物组合物
CN103142774B (zh) 裂果薯总皂苷提取物在抗肝癌与鼻咽癌中的应用
Hu et al. Aloin promotes oral squamous cell carcinoma cell apoptosis and autophagy through Akt/mTOR pathway
CN110496225A (zh) 千金藤碱与自噬抑制剂联用在制备治疗肝癌药物中的应用
CN108057049A (zh) 一种增强细胞活力的中药组合物及其制备方法
CN102068448A (zh) 淫羊藿次苷ⅱ在制备抗黑色素瘤药物中的用途
CN104784475B (zh) 一种用于美白祛斑的中药组方提取物及其应用
CN106075454A (zh) 一种抗肿瘤药物制剂组合
CN105919991B (zh) 泽兰素在制备治疗抑郁症药物中的应用
CN104721620A (zh) 一种增强免疫力的叶类组合物
CN104189038A (zh) 用于调理女性生理健康和免疫功能的中药制剂
CN105434895A (zh) 一种天麻景天膏及其制备方法
CN108888754A (zh) 一种含乌苯美司和trail蛋白的抗肿瘤组合物及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant